FDA NDC Directory · JSON-LD · Markdown

Dexilant

NDC 64764-175 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic namedexlansoprazole
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022287
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsDEXLANSOPRAZOLE (60 mg/1)
Marketing started20100412
Package count7

External sources

Source: openFDA. Public-domain (CC0).